Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells
- 18 April 2006
- journal article
- Published by Elsevier in Biomaterials
- Vol. 27 (23) , 4269-4278
- https://doi.org/10.1016/j.biomaterials.2006.02.033
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- BMP4-Expressing Muscle-Derived Stem Cells Differentiate into Osteogenic Lineage and Improve Bone Healing in Immunocompetent MiceMolecular Therapy, 2002
- Baboon Mesenchymal Stem Cells Can Be Genetically Modified to Secrete Human ErythropoietinIn VivoHuman Gene Therapy, 2001
- Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapyThe Journal of Gene Medicine, 2001
- The Effect of Regional Gene Therapy with Bone Morphogenetic Protein-2-Producing Bone-Marrow Cells on the Repair of Segmental Femoral Defects in Rats*Journal of Bone and Joint Surgery, 1999
- Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces boneBone, 1999
- Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapyThe Journal of Gene Medicine, 1999
- Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivoJournal of Orthopaedic Research, 1999
- Controllable gene therapy pharmaceutics of non-viral gene delivery systemsJournal of Controlled Release, 1996
- Pharmaceutical Approach to Somatic Gene TherapyPharmaceutical Research, 1996
- The new frontier: gene and oligonucleotide therapyPharmaceutica Acta Helvetiae, 1994